This systematic review synthesizes findings from 35 studies involving over 6,000 critically ill adult patients and evaluates the diagnostic performance of three of the most widely studied AKI biomarkers: NGAL, KIM-1, and TIMP-2·IGFBP7. This evidence concerns the gene IGFBP7 and acute kidney injury.